SOX2 and urinary bladder carcinoma: In addition, isorhapontigenin inhibits human bladder cancer invasion via an upstream regulatory Dicer/miR-145/SOX2/miR-365a/RAC1 cascade resulting in MKK7/JNK activation and autophagy induction [129].